IndraLab

Statements

USP22 inhibits MTOR. 3 / 3

| 3

➶

reach

"USP22 reduces the mTOR activity to retard the progression of CRC[8]."

38577450

➶

reach

"USP22 prevents ubiquitination-mediated EGFR degradation, thereby inducing persistent activation of EGFR-mediated oncogenic signaling pathways, such as STAT3, AKT/mTOR, and MEK/ERK pathways."

35935969

➶

reach

"USP22 knockdown protects against cerebral ischemia/reperfusion injury via destabilizing PTEN protein and activating the mTOR/TFEB pathway."

37191727

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP22 inhibits MTOR. 3 / 3

INDRA sources:

Databases

Reading